First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2004-11-23 12:18:14Open Document File Size: 973,44 KBShare Result on FacebookCityMountain View / /CompanyMatrix Systems / Tailored Risk Minimization Matrix Systems / Janssen Medical Affairs LLC / Mylan / J&J / Regulatory ALZA Corporation / Janssen Cilag / ZARS Inc. / Teva / Ingelheim Pharmaceuticals / Than Reservoir Systems / Rate Them As AB / /ContinentNorth America / Europe / /CountryUnited States / /CurrencyUSD / /FacilityStanford University / /IndustryTermreservoir product / reservoir products / transdermal systems / reservoir systems / reservoir technology / transdermal products / pharmaceutical equivalents / opioid product / validation opioid products / television news media / particular prescription opioid products / received considerable media / healthcare providers / /MedicalConditionchronic pain / skin sensitization/phototoxicity / illness / erious injury / fever / pain / prescription drug abuse / breakthrough pain / /OrganizationSannerud C. College / Stanford University / FDA / /PersonSteven L. Shafer / Foley / /Positionpresident / Butler / Susan P. Rinne Vice President / representative / Professor of Anesthesia / /Productacetaminophen / Duragesic / Vicodin / fentanyl / OxyContin / /ProvinceOrStateIndiana / California / /SportsLeagueStanford University / /Technologyreservoir technology / matrix technology / drug delivery / /URLwww.fda.gov/cder/orange/uniterm.htm / http /SocialTag |